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Colorectal cancer is a major cause ofmor-
bidity and mortality in the United States;
it is the third most common site ofcancer in
men after prostate and lung cancer, and the
second most common site of cancer in
women after breast cancer (1). Further-
more, the incidence ofcolorectal cancer is
increasing in industrial countries (2).
Because familial forms ofcolon cancer are
thought to account for only about 15% of
all cases (2), there is a strong likelihood
that both environmental factors and inher-
itance play important roles in the patho-
genesis ofthis disease.
The National Toxicology Program
reported that trihalomethanes, which are
by-products of water chlorination, induce
colorectal cancers in rats (3). Epidemiological
studies also suggest an association between
consumption of chlorination by-products
in drinking water and an increased risk for
colorectal cancer in humans (4). Although
disinfection ofdrinking water by chlorina-
tion has been a major disease prevention
treatment, these findings raise an important
public health concern because of the large
number ofpeople who consume chlorinated
water. In recent years there has been exten-
sive study ofthe molecular events involved
in the development ofhuman colorectal can-
cer. Consequently, the molecular genetics
of colorectal carcinoma are among the best
understood ofany common human cancer.
To foster an exchange of information
and ideas on potential interactions ofenvi-
ronmental factors and molecular genetic
events that may occur in the development
ofcolorectal cancer, a workshop, "Trihalo-
methanes and Other Environmental
Factors That Contribute to Colorectal
Cancer," was held at the National Institute
of Environmental Health Sciences in
Research Triangle Park, North Carolina,
14 September 1993.
The objectives ofthe workshop were 1)
to review the current status ofresearch on
the biology, epidemiology, and genetics of
colorectal cancer, and 2) to identify areas
in which further research would advance
our understanding of the influence of
genetic susceptibility and environmental
factors (e.g., trihalomethanes) on the
occurrence and development ofthis disease
in humans.
Colorectal Carcinogenesis
An overview on the etiology ofcolon cancer,
focusing on mechanistic relationships
between factors identified through studies
ofthe epidemiology, physiology, and mol-
ecular biology ofthis disease was presented.
Increased colon cancer risk has consistently
been associated with increased consumption
of fat, meat, or protein, and the risk rises
markedly with consumption of heavily
browned meats. Decreased risk has been
consistently associated with high consump-
tion ofvegetables (and perhaps fruit) and
with physical activity. Cause-and-effect
relationships are difficult to establish
because ofthe multifaceted and incremen-
tal etiology ofthis disease. Arylamines pro-
duced in cooked meats may provide a link
between diet and genetic susceptibility
because the metabolism of these com-
pounds to DNA-reactive intermediates is
genetically variable. Colon cancer risk is
increased in individuals with high N-oxi-
dation (hepatic P4501A2) and high N-
acetylation (colon NAT2) activities. A
K-ras mutation at codon 12 is consistent
with the formation ofan arylamine adduct
as an early event in the multistep carcino-
genic process. Other than family history,
where two genes have been identified
(APC and hMSH4, there is much uncer-
tainty on how to relate population risk fac-
tors and physiology to molecular genetic
events in colon cancer.
The molecular biology of colorectal
neoplasia has been studied intensely
because this is a relatively common tumor
with well-recognized environmental and
familial aspects and because precursor
lesions are easily identifiable and accessible.
The model generally accepted for this dis-
ease involves changes in the normal epithe-
lium to an abnormal state of proliferation
and differentiation; this is followed by the
development ofbenign neoplasms (adeno-
mas), of which a small subset increases in
size and degree of dysplasia. Eventually,
some ofthese lesions progress to infiltrating
adenocarcinomas. Genetic changes along
this sequence involve a combination of
alterations in oncogenes which drive cellular
proliferation and in tumor-suppressor genes
which lead to dysregulation of normal
growth control. Germline mutations in the
APC (adenomatous polyposis coli) gene
are responsible for familial adenomatous
polyposis, a syndrome characterized phe-
notypically.by the development of hun-
dreds to thousands ofcolorectal adenomas,
with 100% occurrence of colorectal neo-
plasia if colectomy is not performed.
Somatic mutations in the APC gene are
frequent in sporadic colorectal tumors.
The sporadic disease refers to those cases
(about 85%) in which a well-recognized
inherited basis has not been established.
Currently there is no information on how
environmental factors influence sporadic
mutations in the APC gene. APC muta-
tions are probably an early event in the
development ofsporadic neoplasia because
they have been detected in aberrant crypt
foci and in a high percentage ofadenomas.
Most mutations in the APC gene lead to
truncation ofthe gene product. Mutations
in K-rasand N-rasgenes also occur at high
rates in colorectal neoplasms. Because ras
mutations do not increase in frequency as
the adenoma to carcinoma sequence occurs,
it is believed that they are typically early
events.
High rates of deletion of the DCC
(deleted in colorectal cancer) gene and
high rates of mutations and deletions in
the p53 gene have also been observed in
human colorectal neoplasms. These are
late events because they are uncommon in
early adenomas and are increased in fre-
quency in later phase adenomas and in
carcinomas. Some carcinomas do not show
any identifiable abnormalities in the DCC
gene or in p53. One of the functions of
the normal p53 gene product is to arrest
cells with damaged DNA in the GI phase
of the cell cycle and thereby allow DNA
repair before the cells progress to S-phase.
Comparisons of genetic abnormalities in
hereditary and sporadic colorectal cancer
cases reveal nearly equal frequencies of
APC and p53 mutations, whereas ras
mutations may be slightly higher in can-
cers of patients with hereditary nonpoly-
posis colorectal cancer syndrome
(HNPCC).
The replication error phenotype
(RERT), characterized by instability in
microsatellite repeat sequences throughout
the genome, is present in the tumors of
about 75% ofpatients with HNPCC and
in only 10% ofseeminglysporadic tumors.
This instability has been attributed to a
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mutation in a gene (hMSH4 on chromo-
some 2 that results in a defect in
nucleotide mismatch repair. Little or no
information is available on how environ-
mental factors interact at the level of the
genome to affect the molecular genetic
events in colorectal neoplasia.
The multiple intestinal neoplasia (Min)
mouse characterized by Amy Moser ofthe
University of Wisconsin in C57BL6 mice
possesses a nonsense mutation in the APC
gene and is a potential model to study fac-
tors that influence hereditary colorectal
cancer. Mice with a homozygous genotype
die in early embryogenesis; however, het-
erozygous Min mice have a high incidence
of colon cancer. Min reflects the human
phenotype in that the average intestinal
tumor load is greater than 50, all regions of
the intestine are affected, and most of the
intestinal lesions are adenomas with mod-
erate dysplasia. Min mice have detectable
intestinal tumors by 35 days ofage and the
average life span is 120 days. In back-
crosses with other strains of mice, the F,
hybrid mice live longer and have fewer
tumors than the Minl+ C57BL6 strain.
This observation suggests that modifier
genes of the Min phenotype exist.
Treatment of Min mice with exogenous
chemicals (e.g., ethyl nitrosourea) can further
increase tumor development. Therefore,
both environmental and genetic factors can
affect the Min phenotype. Future studies
should determine if environmental factors
affect the progression ofcolorectal carcino-
genesis or influence the expression ofmod-
ifier genes ofthe Min phenotype.
Transforming growth factor a (TGFa)
and TGFf3 can act in an autocrine manner
to regulate the proliferative status of
intestinal epithelial cells, such that the net
balance determines the growth state ofthe
cell. TGFa is an epithelial cell mitogen,
while activated TGFP can override the
growth stimulatory effects of TGFa,
resulting in cessation of growth without
inducing differentiation. As an integral
membrane glycoprotein, TGFa has the
potential to influence adjacent epidermal
growth factor (EGF) receptor-containing
cells. During the transformation process in
colon epithelial cells, overproduction of
TGFc or enhanced signaling through the
EGF receptor may result in growth stimu-
lation and/or there may be loss or a defect
in the growth inhibitory pathways. Ifenvi-
ronmental chemicals bind to receptors of
these growth factors, they may alter the
growth ofintestinal epithelial cells by per-
turbing the balance between the stimula-
tory and inhibitory signal transduction
pathways. Though cancer cells may have
an upregulation ofTGFP, the immuno-
suppressive properties of this factor cou-
pled to the refractoriness of these cells to
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growth inhibition may contribute to the
transformed phenotype. At least six lig-
ands have the potential to bind to the EGF
receptor and signal through that pathway.
Because TGFa expression is not uniformly
increased in expression in colon cancers
compared to normal epithelial tissue, per-
haps other members of the family are also
involved. Further, the selective induction
of specific genes, such as the cyclooxyge-
nase genes, by TGFa may also influence
colon neoplasia. Upregulation of TGFa
has been observed commonly after treat-
mentwith various tumor promoters.
Animal Studies on
Trihalomethanes
Ofthe 435 chemicals studied for their car-
cinogenic potential in long-term rodent
studies by the NCI/NTP, 14 showed evi-
dence of colorectal carcinogenicity in rats.
Two ofthese chemicals that caused marked
increases in tumor incidence were the
brominated trihalomethanes, bromoform,
and bromodichloromethane. Three other
brominated chemicals caused a colon can-
cer response that was greater than 10%.
Oral exposure to bromodichloromethane
caused adenomas or adenocarcinomas in
greater than 90% of the high dose male
rats. This is a dramatic chemical effect
because colorectal cancers are uncommon
in untreated rats, occurring at a rate of
approximately 0.1%.
The morphological characteristics of
the colorectal epithelial tumors induced by
the trihalomethanes are similar to those
observed in human colorectal cancers.
Nodules observed grossly on the mucosal
surface were frequently multiple. Micro-
scopically there was a spectrum of lesions
present in the distal colon and rectum; the
earliest precursor lesion was focal atypical
hyperplasia (corresponding to dysplasia)
with a high mitotic index. These lesions
progressed to adenomas and carcinomas
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mucosa. No metastases were observed in
this study, and the tumor response was
greater in males than in females.
Studies on the biotransformation ofthe
trihalomethanes are in progress and phar-
macokinetic models are being developed to
characterize both the metabolic pathways
that produce carcinogenic intermediates
and the delivery ofthese materials to target
tissues. Bromodichloromethane (BDCM)
can be oxidized by cytochrome P4502EI
or cytochrome P4502BI to phosgene, a
highly reactive intermediate that acylates a
variety of macromolecules or undergoes
hydrolysis to carbon dioxide. The same
enzyme system can act reductively to form
bromide ion and the dehalogenated free
radical intermediate that can interact with
membrane lipids. Alternatively, BDCM
may form a dichloromethyl glutathione
conjugate catalyzed by glutathione-S-trans-
ferase. All pathways of trihalomethane
metabolism lead to reactive intermediates
that potentially interact with DNA.
Interactions with microflora and other
contents of the gastrointestinal tract may
produce additional reactive intermediates.
In vitro studies show that brominated tri-
halomethanes are more active than chloro-
form in forming protein adducts under
aerobic conditions or lipid adducts under
anaerobic conditions. Maximal rates of
cytochrome P4502E1-mediated oxidation
are similar for BDCM and chloroform;
however, qualitative differences in the
uptake and metabolism of these chemicals
in rats indicate that a second metabolic
pathway may be active for BDCM.
Among dihalomethanes, brominated
chemicals have a more favorable reaction
with glutathione-producing mutagenic
intermediates.
Human lymphoblast cell cultures that
had lost their ability to express cytochrome
P450 activity were transfected with various
cytochrome P450 isozymes and exposed to
BDCM. A dose-dependent increase in
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cytotoxicity, which was attributed to meta-
bolic activation of the parent compound,
was observed in cells expressing
cytochrome P4502E1, but not in those
specifically expressing cytochromes 1A2,
2A6, 2B6, or 3A4.
Epidemiological Studies of
Chlorinated Drinking Water
A meta-analysis of data from nine pub-
lished case-control and cohort studies that
examined associations between chlorinated
drinking water and colon cancer, colorectal
cancer, or rectal cancer was presented. By
definition, the exposed groups in this
analysis had higher exposure to chlorina-
tion by-products than the unexposed
groups based on their use ofeither surface
water (versus groundwater) or chlorinated
water (versus unchlorinated or chlorami-
nated water). Relative risk estimates for all
sites included in these studies were com-
piled by pooling the study results.
Although all of the sites had relative risks
greater than one, significant increases were
obtained only for bladder cancer and for
rectal cancer. For those studies that gave
some estimate of exposure, dose responses
for colon and rectal cancer were evident
when the exposure subgroups were catego-
rized as low, moderate, and high. Other
drinking water contaminants, besides the
trihalomethanes, may have contributed
also to the increased risks ofrectal cancer.
An epidemiological study of drinking
water in Iowa residents demonstrated an
association between consumption of chlo-
rination by-products from chlorinated sur-
face water sources and increased risk for
rectal cancer, but not for bladder cancer or
colon cancer. Rectal cancer risk associated
with chlorination by-products appeared to
be influenced by lifestyle factors (e.g.,
physical activity).
Conclusions and Future Needs
A general discussion following the presen-
tations arrived at the following conclu-
sions:
* Both epidemiological data and animal
data indicate that trihalomethanes pose a
potential carcinogenic risk to humans. The
animal studies are considered to be partic-
ularly predictive of potential human risk
because of the site correspondence in
tumor response, the fact that colon and
rectal cancers are uncommon in rodents,
and because morphological features of the
tumors induced in animals are analogous
to those observed in human colorectal
tumors. The Min mouse, which possesses
an APC mutation, is a useful model to
study the influence of environmental fac-
tors on familial adenomatous polyposis.
Because the brominated chemicals are
more active than chlorinated chemicals in
the animal models and because the bromi-
nated trihalomethanes are formed as a
result ofbromide ions in the source water,
epidemiological studies ofcolorectal cancer
in regions with high bromide content in
the source water (e.g., coastal regions)
would yield greater insight on risks associ-
atedwith exposure to trihalomethanes.
* The distinction between rectal cancer
versus colon cancer in many cases is a diffi-
cult one. There are no studies available com-
paring the molecular genetics of tumors at
these two sites. Differences in p53 or ras
gene mutation rates in the proximal versus
distal colon suggest that a gradient of
response rather than absolute distinctions
may exist. Currently it is reasonable to
consider colon and rectal cancers in ani-
mals as arising by a similar process.
* Epidemiological studies ofby-products
ofwater chlorination need better character-
ization ofexposure and greater consideration
of other risk factors. Studies of occupa-
tional cohorts exposed to trihalomethanes
or other brominated chemicals may also
shed light on the relationship between these
chemicals in drinking water and cancer
risk.
* To better understand the mechanisms
ofcancer induction by trihalomethanes, we
need to know what enzymes are involved
in the activation ofthese chemicals and in
particular the relative roles of the cyto-
chrome P450 isozymes and glutathione-S-
transferase. The types and frequencies of
mutations induced by these chemicals in
critical target genes in colorectal tumors in
animal models need to be characterized.
There is no evidence at present for a non-
mutagenic mechanism in trihalomethane-
induced colorectal cancer.
* Polymorphisms that are involved in
either the activation of the chemical (e.g.,
glutathione-S-transferase and cytochrome
P4502E1), the deactivation of mutagenic
intermediates, or the control ofthe disease
process (e.g., oncogenes and tumor-sup-
pressor genes) can influence the cancer risk
associated with exposure to environmental
carcinogens. In addition, the degree of
induction of inducible metabolic enzymes
can show substantial interindividual vari-
ability and environmental factors may
influence the expression ofvarious genetic
susceptibilities. Thus, genetically susceptible
subpopulations should be identified and
analyzed separately for their cancer risk.
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